Jeffrey Mazzatta, DPM
Foot & Ankle Surgery · Manahawkin, NJNPI 1417059304
Payments from drug & device makers
Across 127 payments — averaging $73.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Organogenesis Inc.$1K
- Paragon 28, Inc.$1K
- Treace Medical Concepts, Inc.$1K
- Biotissue Holdings Inc.$1K
- Stryker$737
- plus $2K from 12 others
What the payments were for
- Travel & lodging$3,86841%
- Food & beverage$3,84941%
- Education$1,63317%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 17 | $2,079 |
| Organogenesis Inc. | 36 | $1,173 |
| Paragon 28, Inc. | 6 | $1,172 |
| Treace Medical Concepts, Inc. | 17 | $1,142 |
| Biotissue Holdings Inc. | 3 | $1,056 |
| Stryker(2 entities) | 9 | $737 |
| Eclipse Technology Solutions Inc. | 5 | $691 |
| Liberty Surgical Inc. | 2 | $428 |
| Medtronic(2 entities) | 6 | $338 |
| AbbVie | 13 | $240 |
| Kerecis Limited | 2 | $73 |
| Convatec Inc. | 2 | $53 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $45 |
| Solventum Corporation | 2 | $44 |
| Medshape, Inc. | 1 | $29 |
| Integra Lifesciences Corporation | 1 | $27 |
| Acera Surgical, Inc. | 1 | $16 |
| Advanced Oxygen Therapy Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty$340
- ClosureFast$222
- CUT GUIDE$216
- 7 X 23MM CITRELOCK IMPLANT$137
- AUGMENT INJECTABLE$128
- Actishield$126
- Lapiplasty System$125
- AUGMENT$109
- Apligraf$101
- Dermagraft$101
- Puraply/Affinity/NuTech$101
How this compares
$9,350 in reported general payments places this provider in the 85th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 47 | $696 |
| Gabapentin | 14 | $336 |
| Mupirocin | 23 | $203 |
| Cephalexin | 12 | $140 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $73 |
| Ciprofloxacin Hcl | 12 | $34 |
| Prednisone | 14 | $12 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Manahawkin
- Wayne BerberianNewark$2M
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$847K
- Shane HollawellManasquan$753K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Sheldon LinNewark$253K
- Mark SolomonCedar Knolls$232K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.